All

What are you looking for?

All
Projects
Results
Organizations

Quick search

  • Projects supported by TA ČR
  • Excellent projects
  • Projects with the highest public support
  • Current projects

Smart search

  • That is how I find a specific +word
  • That is how I leave the -word out of the results
  • “That is how I can find the whole phrase”

Diabetes Therapy With SGLT2i After Heart Transplant: A Multi-Institutional Analysis

The result's identifiers

  • Result code in IS VaVaI

    <a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00023001%3A_____%2F25%3A00085717" target="_blank" >RIV/00023001:_____/25:00085717 - isvavai.cz</a>

  • Result on the web

    <a href="https://www.sciencedirect.com/science/article/pii/S2213177925004470?via%3Dihub" target="_blank" >https://www.sciencedirect.com/science/article/pii/S2213177925004470?via%3Dihub</a>

  • DOI - Digital Object Identifier

    <a href="http://dx.doi.org/10.1016/j.jchf.2025.102520" target="_blank" >10.1016/j.jchf.2025.102520</a>

Alternative languages

  • Result language

    angličtina

  • Original language name

    Diabetes Therapy With SGLT2i After Heart Transplant: A Multi-Institutional Analysis

  • Original language description

    Heart transplantation markedly improves health-related quality of life and survival in patients with advanced heart failure. However, heart transplant (HT) recipients remain at elevated risk for chronic kidney disease (CKD) andcardiovascular morbidity and mortality. Diabetesis common after HT procedures and further increases the risk of CKD and cardiovascular disease. Mitigating the negative effects of thesecomorbidities is a critical unmet need. Sodium glucosecotransporter 2 inhibitors (SGLT2is) mprove outcomes in patients with diabetes, heartfailure, and/or CKD who are not HT recipients. SGLT2i may offer similar benefits after transplantation, but HT recipients were excluded from the pivotal clinical trials of SGLT2i.

  • Czech name

  • Czech description

Classification

  • Type

    J<sub>imp</sub> - Article in a specialist periodical, which is included in the Web of Science database

  • CEP classification

  • OECD FORD branch

    30201 - Cardiac and Cardiovascular systems

Result continuities

  • Project

    <a href="/en/project/LX22NPO5104" target="_blank" >LX22NPO5104: National Institute for Research of Metabolic and Cardiovascular Diseases</a><br>

  • Continuities

    P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)

Others

  • Publication year

    2025

  • Confidentiality

    S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Data specific for result type

  • Name of the periodical

    JACC. Heart failure

  • ISSN

    2213-1779

  • e-ISSN

    2213-1787

  • Volume of the periodical

    13

  • Issue of the periodical within the volume

    8

  • Country of publishing house

    US - UNITED STATES

  • Number of pages

    4

  • Pages from-to

    "art. no. 102520"

  • UT code for WoS article

    001546012800001

  • EID of the result in the Scopus database

    2-s2.0-105008796537